Kjell Svensson - Concepedia

Author

Kjell Svensson

Also Known As

K A Svensson, K Svensson, K. A. Svensson, K. SVENSSON, K. Svensson, K.A Svensson, K.A. Svensson, Kjell A Svensson, Kjell A. Svensson, Kjell Svensson

178

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University of Gothenburg Eli Lilly (United States)W.E. Upjohn Institute for Employment Research Eli Lilly (United Kingdom)Karolinska Institutet

About

Kjell Svensson is an author at University of Gothenburg specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	59	3.2K
2	Social Sciences	20	33	1.9K
3	Health Sciences	7	7	520
4	Natural Sciences	7	7	202
5	Education	1	1	36

Kjell Svensson

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity Nicholas Waters, Kjell Svensson, Susanne R. Haadsma‐Svensson, Journal of Neural Transmission Health SciencesPostsynaptic Receptor InhibitoryFunctional SelectivityPhysiologyNeurotransmitter	1993	256
Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) Jörgen A. Engel, Stephan Hjorth, Kjell Svensson, European Journal of Pharmacology Molecular PharmacologyPsychoactive DrugMedicinePsychopharmacologyNeuropharmacology	1984	221
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat Chad J. Swanson, Kenneth W. Perry, Susanne Koch-Krueger, Neuropharmacology NeuropsychologySeveral Brain RegionsAttention Deficit/hyperactivityCognitive NeurosciencePsychiatry	2006	214
Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (–)-(1 R, 4 S,5 S,6 S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039) Matthew Fell, Kjell Svensson, Bryan G. Johnson, Journal of Pharmacology and Experimental Therapeutics	2008	206
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP Stephan Hjorth, Arvid Carlsson, David Clark, Psychopharmacology Antagonist ActionsFunctional SelectivityMedicineNeuropharmacologyPharmacotherapy	1983	201
Mesotelencephalic dopamine system and reproductive behavior in the female rat: Effects of ventral tegmental 6-hydroxydopamine lesions on maternal and sexual responsiveness. Stefan Hansen, Christina Harthon, E. U. Wallin, Behavioral Neuroscience Sexual ResponsivenessBehavioral NeuroscienceNeuroanatomyMesotelencephalic Dopamine SystemMedicine	1991	185
The effects of 6-OHDA-induced dopamine depletions in the ventral or dorsal striatum on maternal and sexual behavior in the female rat S. Hansen, Christina Harthon, E. U. Wallin, Pharmacology Biochemistry and Behavior Behavioral SciencesNeuropsychology6-Ohda-induced Dopamine DepletionsDorsal StriatumBehavioral Neuroscience	1991	157
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors Kjell Svensson, Arvid Carlsson, Rita M. Huff, European Journal of Pharmacology Neurobiological MechanismBehavioral SciencesNeuropsychologyFunctional DifferencesPsychiatry	1994	140
(+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists Kjell Svensson, Anette M. Johansson, Tor Magnusson, Naunyn-Schmiedeberg s Archives of Pharmacology Functional SelectivityAddictionMedicinePsychopharmacologyNeuropharmacology	1986	134
Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release Kjell Svensson, Arvid Carlsson, Nicholas Waters Journal of Neural Transmission Functional SelectivityMedicinePhysiologyLocomotor InhibitionNeuropharmacology	1994	132

Page 1